Home  >  News

Filter your search

Clear All Filters

Sale Labsave Facebook Like Us Biosave Newsletter Signup Filter Biosave Filter

News

OGT launches high-resolution, high-throughput PGS array
OGT launches high-resolution, high-throughput PGS array
Oxford Gene Technology
08/07/2014

Confident genome-wide aneuploidy detection in 14 samples on a single array Oxford, UK – 08 July 2014. Oxford Gene Technology (OGT), The Molecular Genetics Company, has announced the launch of a new high-resolution, high-throughput pre-implantation genetic screening (PGS) microarray aimed at improving embryo screening for in vitro fertilisation (IVF). The CytoSure™ Embryo Screen Array offers eight arrays of 60,000 spots for high-resolution genome-wide...
New updates to leading aCGH data analysis software
New updates to leading aCGH data analysis software
Oxford Gene Technology
25/03/2014

OGT releases new CytoSure™ Interpret Software to enhance CNV detectionOxford, UK – 25 March 2014. Oxford Gene Technology (OGT), The Molecular Genetics Company, is pleased to announce the latest version (4.5.3) of its class-leading CytoSure™ Interpret Software. Complimentary with all CytoSure array purchases, CytoSure Interpret Software is a powerful and easy-to-use package for the analysis of aCGH data, the gold-standard for copy number variation (CNV)...
OGT’s Christmas challenge — throw a snowball to win an Amazon Kindle Fire
OGT’s Christmas challenge — throw a snowball to win an Amazon Kindle Fire
Oxford Gene Technology
18/12/2013

Oxford, UK – 18 December 2013. Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, is providing some festive fun this holiday season with its interactive Christmas Snowball Challenge. In the spirit of giving, OGT has once again decided to send an electronic Christmas card in place of paper cards and will instead make a donation to a number of charities. The e-card features the return of...
A snapshot of the NGS market — user views
A snapshot of the NGS market — user views
Oxford Gene Technology
21/08/2013

Oxford, UK – 21 August 2013. Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has released the results from a recent survey of researchers using next generation sequencing. The survey was designed to investigate current trends in NGS usage and determine future demands; to aid OGT in continuing to deliver high-quality, up-to-date services and provide insightful, relevant customer resources....
OGT to launch new cancer focused CytoSure™ array at CCMC meeting
OGT to launch new cancer focused CytoSure™ array at CCMC meeting
Oxford Gene Technology
30/07/2013

Oxford, UK – 30 July 2013. Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, will launch its new CytoSure™ Consortium Cancer +SNP array (4x180k) at the Cancer Cytogenomics Microarray Consortium (CCMC) and Cytogenomics Array Group (CAGdb) combined meeting in Chicago on the 5th- 7th August, booth 4.The new CytoSure™ Consortium Cancer +SNP array allows the simultaneous detection of...
OGT Expands NGS Offering with Targeted Familial Sequencing and Analysis
OGT Expands NGS Offering with Targeted Familial Sequencing and Analysis
Oxford Gene Technology
30/04/2013

Oxford, UK – 30 April 2013. Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has extended its high-quality whole exome sequencing services with a targeted Familial Sequencing and Analysis Service. Ideal for investigators of inherited disease, the new service delivers multi-genome analysis of related samples for the detection of causative, de novo and disease susceptibility mutations. With a...
OGT releases new CytoSure™ microarray for research into haematological and solid cancers
OGT releases new CytoSure™ microarray for research into haematological and solid cancers
Oxford Gene Technology
25/03/2013

Simultaneous detection of CNVs, SNPs and LOH on a single array using any reference sampleOxford, UK – 25 March 2013. Oxford Gene Technology (OGT), provider of innovative genetics research and biomarker solutions to advance molecular medicine, has released a new microarray to improve the accuracy and efficiency of cancer research. The CytoSure™ Cancer +SNP array (4x180k) combines long oligo array comparative genomic hybridisation (aCGH) probes with fully...
OGT to discuss the latest genomic tools for cytogeneticists at AMP and ASHG 2012
OGT to discuss the latest genomic tools for cytogeneticists at AMP and ASHG 2012
Oxford Gene Technology
15/10/2012

Enhanced analysis using CytoSure™ arrays for simultaneous aCGH and SNP detectionOxford, UK – 15 October 2012. Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, will be hosting booths at two key US cytogenetics meetings over the next few weeks. The first is the Association for Molecular Pathology (AMP) Annual Meeting on Genomic Medicine 2012 to be held in Long Beach, CA (25-27...
Button_on Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave Button_off_biosave